Latest News for CVALF
Covalon Technologies Ltd. (COV:CA) Q3 2026 Earnings Call Transcript
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 third quarter results for the period ended June 30, 2026. Full financial statements and management's discussion and analysis are available on the Company's profile at www.sedarplus.ca. Brent Ashton, Covalon's Chief Executive…
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2026 results on Thursday, August 27, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, August 27, 2026, at 8:30am ET. To view, listen to, and participate in the live…
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the appointment of Dr. Murray Miller to its Board of Directors (“Board”) as an independent director subject to TSX Venture Exchange approval. Dr. Miller graduated as a Medical Doctor from the University of Manitoba in 1982. He completed his…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for CVALF.
Senate Trading
No Senate trades found for CVALF.
U.S. House Trading
No House trades found for CVALF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.